Table 1.
Patient Characteristics
| Non-CLL MD (n=536) |
CLL MD (n=773) |
P-value | ||
|---|---|---|---|---|
| Median Age at Diagnosis (range) | 66.3 (38–95) | 63.2 (28–97) | <0.001 | |
| Male | 347 (62%) | 513 (66%) | 0.54 | |
| Rai Risk at diagnosis | ||||
| Low (Rai stage 0) | 242 (46%) | 457 (59%) | <0.001 | |
| Intermediate (Rai stage I–II) | 267 (50%) | 286 (37%) | ||
| High (Rai stage III–IV) | 23 (4%) | 26 (3%) | ||
| Missing | 4 | 4 | ||
| ALC (× 109/L), median | 7.1 | 9.8 | ||
| ≤30 | 451 (93%) | 634 (86%) | <0.001 | |
| >30 | 36 (7%) | 104 (14%) | ||
| Missing | 49 | 35 | ||
| Proximity Patient Residence to Mayo Clinic | ||||
| <120 miles (e.g. 2 hour drive) | 238 (45%) | 361 (48%) | 0.29 | |
| <300 miles (e.g. 5 hour drive) | 401 (76%) | 570 (76%) | 0.98 | |
| Missing | 8 | 22 | ||
| Received stem cell transplant during course* | 6 (1.1%) | 8 (1.0%) | 1.0 | |
*
in total 14/1309 patients (1.1%) received stem cell transplant (11 allogenic; 3 autologous)